APO Research
Talk to an analyst

APO RESEARCH · REPORT

Blinatumomab

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Blinatumomab Market Analysis and Forecast 2026-2032

22 December 2025198 pages

Choose your research edition.

Industry ResearchBlinatumomab Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Blinatumomab Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal Blinatumomab Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Blinatumomab Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Blinatumomab Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Blinatumomab market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Blinatumomab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Blinatumomab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Blinatumomab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Blinatumomab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Blinatumomab include Amgen. etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Blinatumomab, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Blinatumomab, also provides the sales of main regions and countries. Of the upcoming market potential for Blinatumomab, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Blinatumomab sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Blinatumomab market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Blinatumomab sales, projected growth trends, production technology, application and end-user industry.

Blinatumomab Segment by Company

Amgen

Blinatumomab Segment by Type

Non-prefilled

Prefilled

Blinatumomab Segment by Application

Hospital

Pharmacy

Blinatumomab Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blinatumomab market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Blinatumomab and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blinatumomab.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Blinatumomab in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Blinatumomab manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Blinatumomab sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Blinatumomab Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Non-prefilled Major Manufacturers Table 3. Prefilled Major Manufacturers Table 4. Global Blinatumomab Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Pharmacy Major Manufacturers Table 7. Blinatumomab Industry Trends Table 8. Blinatumomab Industry Drivers Table 9. Blinatumomab Industry Opportunities and Challenges Table 10. Blinatumomab Industry Restraints Table 11. Global Blinatumomab Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Blinatumomab Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Blinatumomab Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Blinatumomab Revenue Market Share by Region (2021-2026) Table 15. Global Blinatumomab Revenue Market Share by Region (2027-2032) Table 16. Global Blinatumomab Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 17. Global Blinatumomab Sales by Region (2021-2026) & (k units) Table 18. Global Blinatumomab Sales by Region (2027-2032) & (k units) Table 19. Global Blinatumomab Sales Market Share by Region (2021-2026) Table 20. Global Blinatumomab Sales Market Share by Region (2027-2032) Table 21. Global Blinatumomab Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Blinatumomab Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Blinatumomab Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Blinatumomab Sales Market Share by Manufacturers (2021-2026) Table 25. Global Blinatumomab Sales Price (US$/unit) of Manufacturers (2021-2026) Table 26. Global Blinatumomab Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Blinatumomab Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Blinatumomab Manufacturers, Product Type & Application Table 29. Global Blinatumomab Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Blinatumomab by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Blinatumomab Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Blinatumomab Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Blinatumomab Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Blinatumomab Revenue Market Share by Type (2021-2026) Table 36. Global Blinatumomab Revenue Market Share by Type (2027-2032) Table 37. Global Blinatumomab Sales by Type 2021 VS 2025 VS 2032 (k units) Table 38. Global Blinatumomab Sales by Type (2021-2026) & (k units) Table 39. Global Blinatumomab Sales by Type (2027-2032) & (k units) Table 40. Global Blinatumomab Sales Market Share by Type (2021-2026) Table 41. Global Blinatumomab Sales Market Share by Type (2027-2032) Table 42. Global Blinatumomab Price by Type (2021-2026) & (US$/unit) Table 43. Global Blinatumomab Price by Type (2027-2032) & (US$/unit) Table 44. Global Blinatumomab Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Blinatumomab Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Blinatumomab Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Blinatumomab Revenue Market Share by Application (2021-2026) Table 48. Global Blinatumomab Revenue Market Share by Application (2027-2032) Table 49. Global Blinatumomab Sales by Application 2021 VS 2025 VS 2032 (k units) Table 50. Global Blinatumomab Sales by Application (2021-2026) & (k units) Table 51. Global Blinatumomab Sales by Application (2027-2032) & (k units) Table 52. Global Blinatumomab Sales Market Share by Application (2021-2026) Table 53. Global Blinatumomab Sales Market Share by Application (2027-2032) Table 54. Global Blinatumomab Price by Application (2021-2026) & (US$/unit) Table 55. Global Blinatumomab Price by Application (2027-2032) & (US$/unit) Table 56. Amgen Company Information Table 57. Amgen Business Overview Table 58. Amgen Blinatumomab Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 59. Amgen Blinatumomab Product Portfolio Table 60. Amgen Recent Development Table 61. North America Blinatumomab Revenue by Type (2021-2026) & (US$ Million) Table 62. North America Blinatumomab Revenue by Type (2027-2032) & (US$ Million) Table 63. North America Blinatumomab Sales by Type (2021-2026) & (k units) Table 64. North America Blinatumomab Sales by Type (2027-2032) & (k units) Table 65. North America Blinatumomab Sales Price by Type (2021-2026) & (US$/unit) Table 66. North America Blinatumomab Sales Price by Type (2027-2032) & (US$/unit) Table 67. North America Blinatumomab Revenue by Application (2021-2026) & (US$ Million) Table 68. North America Blinatumomab Revenue by Application (2027-2032) & (US$ Million) Table 69. North America Blinatumomab Sales by Application (2021-2026) & (k units) Table 70. North America Blinatumomab Sales by Application (2027-2032) & (k units) Table 71. North America Blinatumomab Sales Price by Application (2021-2026) & (US$/unit) Table 72. North America Blinatumomab Sales Price by Application (2027-2032) & (US$/unit) Table 73. North America Blinatumomab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 74. North America Blinatumomab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 75. North America Blinatumomab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 76. North America Blinatumomab Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 77. North America Blinatumomab Sales by Country (2021-2026) & (k units) Table 78. North America Blinatumomab Sales by Country (2027-2032) & (k units) Table 79. North America Blinatumomab Sales Price by Country (2021-2026) & (US$/unit) Table 80. North America Blinatumomab Sales Price by Country (2027-2032) & (US$/unit) Table 81. United States Blinatumomab Revenue (2021-2032) & (US$ Million) Table 82. Canada Blinatumomab Revenue (2021-2032) & (US$ Million) Table 83. Mexico Blinatumomab Revenue (2021-2032) & (US$ Million) Table 84. Europe Blinatumomab Revenue by Type (2021-2026) & (US$ Million) Table 85. Europe Blinatumomab Revenue by Type (2027-2032) & (US$ Million) Table 86. Europe Blinatumomab Sales by Type (2021-2026) & (k units) Table 87. Europe Blinatumomab Sales by Type (2027-2032) & (k units) Table 88. Europe Blinatumomab Sales Price by Type (2021-2026) & (US$/unit) Table 89. Europe Blinatumomab Sales Price by Type (2027-2032) & (US$/unit) Table 90. Europe Blinatumomab Revenue by Application (2021-2026) & (US$ Million) Table 91. Europe Blinatumomab Revenue by Application (2027-2032) & (US$ Million) Table 92. Europe Blinatumomab Sales by Application (2021-2026) & (k units) Table 93. Europe Blinatumomab Sales by Application (2027-2032) & (k units) Table 94. Europe Blinatumomab Sales Price by Application (2021-2026) & (US$/unit) Table 95. Europe Blinatumomab Sales Price by Application (2027-2032) & (US$/unit) Table 96. Europe Blinatumomab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. Europe Blinatumomab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 98. Europe Blinatumomab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 99. Europe Blinatumomab Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 100. Europe Blinatumomab Sales by Country (2021-2026) & (k units) Table 101. Europe Blinatumomab Sales by Country (2027-2032) & (k units) Table 102. Europe Blinatumomab Sales Price by Country (2021-2026) & (US$/unit) Table 103. Europe Blinatumomab Sales Price by Country (2027-2032) & (US$/unit) Table 104. Germany Blinatumomab Revenue (2021-2032) & (US$ Million) Table 105. France Blinatumomab Revenue (2021-2032) & (US$ Million) Table 106. U.K. Blinatumomab Revenue (2021-2032) & (US$ Million) Table 107. Italy Blinatumomab Revenue (2021-2032) & (US$ Million) Table 108. Russia Blinatumomab Revenue (2021-2032) & (US$ Million) Table 109. Spain Blinatumomab Revenue (2021-2032) & (US$ Million) Table 110. Netherlands Blinatumomab Revenue (2021-2032) & (US$ Million) Table 111. Switzerland Blinatumomab Revenue (2021-2032) & (US$ Million) Table 112. Sweden Blinatumomab Revenue (2021-2032) & (US$ Million) Table 113. Poland Blinatumomab Revenue (2021-2032) & (US$ Million) Table 114. China Blinatumomab Revenue by Type (2021-2026) & (US$ Million) Table 115. China Blinatumomab Revenue by Type (2027-2032) & (US$ Million) Table 116. China Blinatumomab Sales by Type (2021-2026) & (k units) Table 117. China Blinatumomab Sales by Type (2027-2032) & (k units) Table 118. China Blinatumomab Sales Price by Type (2021-2026) & (US$/unit) Table 119. China Blinatumomab Sales Price by Type (2027-2032) & (US$/unit) Table 120. China Blinatumomab Revenue by Application (2021-2026) & (US$ Million) Table 121. China Blinatumomab Revenue by Application (2027-2032) & (US$ Million) Table 122. China Blinatumomab Sales by Application (2021-2026) & (k units) Table 123. China Blinatumomab Sales by Application (2027-2032) & (k units) Table 124. China Blinatumomab Sales Price by Application (2021-2026) & (US$/unit) Table 125. China Blinatumomab Sales Price by Application (2027-2032) & (US$/unit) Table 126. Asia Blinatumomab Revenue by Type (2021-2026) & (US$ Million) Table 127. Asia Blinatumomab Revenue by Type (2027-2032) & (US$ Million) Table 128. Asia Blinatumomab Sales by Type (2021-2026) & (k units) Table 129. Asia Blinatumomab Sales by Type (2027-2032) & (k units) Table 130. Asia Blinatumomab Sales Price by Type (2021-2026) & (US$/unit) Table 131. Asia Blinatumomab Sales Price by Type (2027-2032) & (US$/unit) Table 132. Asia Blinatumomab Revenue by Application (2021-2026) & (US$ Million) Table 133. Asia Blinatumomab Revenue by Application (2027-2032) & (US$ Million) Table 134. Asia Blinatumomab Sales by Application (2021-2026) & (k units) Table 135. Asia Blinatumomab Sales by Application (2027-2032) & (k units) Table 136. Asia Blinatumomab Sales Price by Application (2021-2026) & (US$/unit) Table 137. Asia Blinatumomab Sales Price by Application (2027-2032) & (US$/unit) Table 138. Asia Blinatumomab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Asia Blinatumomab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 140. Asia Blinatumomab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 141. Asia Blinatumomab Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 142. Asia Blinatumomab Sales by Country (2021-2026) & (k units) Table 143. Asia Blinatumomab Sales by Country (2027-2032) & (k units) Table 144. Asia Blinatumomab Sales Price by Country (2021-2026) & (US$/unit) Table 145. Asia Blinatumomab Sales Price by Country (2027-2032) & (US$/unit) Table 146. Japan Blinatumomab Revenue (2021-2032) & (US$ Million) Table 147. South Korea Blinatumomab Revenue (2021-2032) & (US$ Million) Table 148. India Blinatumomab Revenue (2021-2032) & (US$ Million) Table 149. Australia Blinatumomab Revenue (2021-2032) & (US$ Million) Table 150. Taiwan Blinatumomab Revenue (2021-2032) & (US$ Million) Table 151. Southeast Asia Blinatumomab Revenue (2021-2032) & (US$ Million) Table 152. SAMEA Blinatumomab Revenue by Type (2021-2026) & (US$ Million) Table 153. SAMEA Blinatumomab Revenue by Type (2027-2032) & (US$ Million) Table 154. SAMEA Blinatumomab Sales by Type (2021-2026) & (k units) Table 155. SAMEA Blinatumomab Sales by Type (2027-2032) & (k units) Table 156. SAMEA Blinatumomab Sales Price by Type (2021-2026) & (US$/unit) Table 157. SAMEA Blinatumomab Sales Price by Type (2027-2032) & (US$/unit) Table 158. SAMEA Blinatumomab Revenue by Application (2021-2026) & (US$ Million) Table 159. SAMEA Blinatumomab Revenue by Application (2027-2032) & (US$ Million) Table 160. SAMEA Blinatumomab Sales by Application (2021-2026) & (k units) Table 161. SAMEA Blinatumomab Sales by Application (2027-2032) & (k units) Table 162. SAMEA Blinatumomab Sales Price by Application (2021-2026) & (US$/unit) Table 163. SAMEA Blinatumomab Sales Price by Application (2027-2032) & (US$/unit) Table 164. SAMEA Blinatumomab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. SAMEA Blinatumomab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 166. SAMEA Blinatumomab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 167. SAMEA Blinatumomab Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 168. SAMEA Blinatumomab Sales by Country (2021-2026) & (k units) Table 169. SAMEA Blinatumomab Sales by Country (2027-2032) & (k units) Table 170. SAMEA Blinatumomab Sales Price by Country (2021-2026) & (US$/unit) Table 171. SAMEA Blinatumomab Sales Price by Country (2027-2032) & (US$/unit) Table 172. Brazil Blinatumomab Revenue (2021-2032) & (US$ Million) Table 173. Argentina Blinatumomab Revenue (2021-2032) & (US$ Million) Table 174. Chile Blinatumomab Revenue (2021-2032) & (US$ Million) Table 175. Colombia Blinatumomab Revenue (2021-2032) & (US$ Million) Table 176. Peru Blinatumomab Revenue (2021-2032) & (US$ Million) Table 177. Saudi Arabia Blinatumomab Revenue (2021-2032) & (US$ Million) Table 178. Israel Blinatumomab Revenue (2021-2032) & (US$ Million) Table 179. UAE Blinatumomab Revenue (2021-2032) & (US$ Million) Table 180. Turkey Blinatumomab Revenue (2021-2032) & (US$ Million) Table 181. Iran Blinatumomab Revenue (2021-2032) & (US$ Million) Table 182. Egypt Blinatumomab Revenue (2021-2032) & (US$ Million) Table 183. Key Raw Materials Table 184. Raw Materials Key Suppliers Table 185. Blinatumomab Distributors List Table 186. Blinatumomab Customers List Table 187. Research Programs/Design for This Report Table 188. Authors List of This Report Table 189. Secondary Sources Table 190. Primary Sources List of Figures Figure 1. Blinatumomab Image Figure 2. Global Blinatumomab Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Blinatumomab Market Size Share 2021 VS 2025 VS 2032 Figure 4. Non-prefilled Image Figure 5. Prefilled Image Figure 6. Global Blinatumomab Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Blinatumomab Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Pharmacy Image Figure 10. Global Blinatumomab Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Blinatumomab Revenue (2021-2032) & (US$ Million) Figure 12. Global Blinatumomab Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Blinatumomab Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Blinatumomab Revenue Market Share by Region (2021-2032) Figure 15. Global Blinatumomab Sales (2021-2032) & (k units) Figure 16. Global Blinatumomab Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 17. Global Blinatumomab Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Blinatumomab Sales YoY (2021-2032) & (k units) Figure 19. Europe Blinatumomab Sales YoY (2021-2032) & (k units) Figure 20. China Blinatumomab Sales YoY (2021-2032) & (k units) Figure 21. Asia (Excluding China) Blinatumomab Sales YoY (2021-2032) & (k units) Figure 22. South America, Middle East and Africa Blinatumomab Sales YoY (2021-2032) & (k units) Figure 23. Global Blinatumomab Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Blinatumomab Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Blinatumomab Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Blinatumomab Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Blinatumomab Revenue Market Share by Type (2021-2032) Figure 29. Global Blinatumomab Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 30. Global Blinatumomab Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Blinatumomab Sales Market Share by Type (2021-2032) Figure 32. Global Blinatumomab Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Blinatumomab Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Blinatumomab Revenue Market Share by Application (2021-2032) Figure 35. Global Blinatumomab Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 36. Global Blinatumomab Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Blinatumomab Sales Market Share by Application (2021-2032) Figure 38. North America Blinatumomab Revenue Share by Type (2021-2032) Figure 39. North America Blinatumomab Sales Share by Type (2021-2032) Figure 40. North America Blinatumomab Revenue Share by Application (2021-2032) Figure 41. North America Blinatumomab Sales Share by Application (2021-2032) Figure 42. North America Blinatumomab Revenue Share by Country (2021-2032) Figure 43. North America Blinatumomab Sales Share by Country (2021-2032) Figure 44. Europe Blinatumomab Revenue Share by Type (2021-2032) Figure 45. Europe Blinatumomab Sales Share by Type (2021-2032) Figure 46. Europe Blinatumomab Revenue Share by Application (2021-2032) Figure 47. Europe Blinatumomab Sales Share by Application (2021-2032) Figure 48. Europe Blinatumomab Revenue Share by Country (2021-2032) Figure 49. Europe Blinatumomab Sales Share by Country (2021-2032) Figure 50. China Blinatumomab Revenue Share by Type (2021-2032) Figure 51. China Blinatumomab Sales Share by Type (2021-2032) Figure 52. China Blinatumomab Revenue Share by Application (2021-2032) Figure 53. China Blinatumomab Sales Share by Application (2021-2032) Figure 54. Asia Blinatumomab Revenue Share by Type (2021-2032) Figure 55. Asia Blinatumomab Sales Share by Type (2021-2032) Figure 56. Asia Blinatumomab Revenue Share by Application (2021-2032) Figure 57. Asia Blinatumomab Sales Share by Application (2021-2032) Figure 58. Asia Blinatumomab Revenue Share by Country (2021-2032) Figure 59. Asia Blinatumomab Sales Share by Country (2021-2032) Figure 60. SAMEA Blinatumomab Revenue Share by Type (2021-2032) Figure 61. SAMEA Blinatumomab Sales Share by Type (2021-2032) Figure 62. SAMEA Blinatumomab Revenue Share by Application (2021-2032) Figure 63. SAMEA Blinatumomab Sales Share by Application (2021-2032) Figure 64. SAMEA Blinatumomab Revenue Share by Country (2021-2032) Figure 65. SAMEA Blinatumomab Sales Share by Country (2021-2032) Figure 66. Blinatumomab Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Blinatumomab Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Non-prefilled
  • Prefilled
Applications
  • Hospital
  • Pharmacy
Companies covered
  • Amgen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Blinatumomab Market by Type
  3. 1.2.1 Global Blinatumomab Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Non-prefilled
  5. 1.2.3 Prefilled
  6. 1.3 Blinatumomab Market by Application
  7. 1.3.1 Global Blinatumomab Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Pharmacy
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Blinatumomab Market Dynamics
  1. 2.1 Blinatumomab Industry Trends
  2. 2.2 Blinatumomab Industry Drivers
  3. 2.3 Blinatumomab Industry Opportunities and Challenges
  4. 2.4 Blinatumomab Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Blinatumomab Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Blinatumomab Revenue by Region
  3. 3.2.1 Global Blinatumomab Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Blinatumomab Revenue by Region (2021-2026)
  5. 3.2.3 Global Blinatumomab Revenue by Region (2027-2032)
  6. 3.2.4 Global Blinatumomab Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Blinatumomab Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Blinatumomab Sales by Region
  9. 3.4.1 Global Blinatumomab Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Blinatumomab Sales by Region (2021-2026)
  11. 3.4.3 Global Blinatumomab Sales by Region (2027-2032)
  12. 3.4.4 Global Blinatumomab Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Blinatumomab Revenue by Manufacturers
  2. 4.1.1 Global Blinatumomab Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Blinatumomab Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Blinatumomab Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Blinatumomab Sales by Manufacturers
  6. 4.2.1 Global Blinatumomab Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Blinatumomab Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Blinatumomab Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Blinatumomab Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Blinatumomab Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Blinatumomab Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Blinatumomab Manufacturers, Product Type & Application
  13. 4.7 Global Blinatumomab Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Blinatumomab Market CR5 and HHI
  16. 4.8.2 2025 Blinatumomab Tier 1, Tier 2, and Tier 3
5 Blinatumomab Market by Type
  1. 5.1 Global Blinatumomab Revenue by Type
  2. 5.1.1 Global Blinatumomab Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Blinatumomab Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Blinatumomab Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Blinatumomab Sales by Type
  6. 5.2.1 Global Blinatumomab Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Blinatumomab Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Blinatumomab Sales Market Share by Type (2021-2032)
  9. 5.3 Global Blinatumomab Price by Type
6 Blinatumomab Market by Application
  1. 6.1 Global Blinatumomab Revenue by Application
  2. 6.1.1 Global Blinatumomab Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Blinatumomab Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Blinatumomab Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Blinatumomab Sales by Application
  6. 6.2.1 Global Blinatumomab Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Blinatumomab Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Blinatumomab Sales Market Share by Application (2021-2032)
  9. 6.3 Global Blinatumomab Price by Application
7 Company Profiles
  1. 7.1 Amgen
  2. 7.1.1 Amgen Company Information
  3. 7.1.2 Amgen Business Overview
  4. 7.1.3 Amgen Blinatumomab Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Amgen Blinatumomab Product Portfolio
  6. 7.1.5 Amgen Recent Developments
8 North America
  1. 8.1 North America Blinatumomab Market Size by Type
  2. 8.1.1 North America Blinatumomab Revenue by Type (2021-2032)
  3. 8.1.2 North America Blinatumomab Sales by Type (2021-2032)
  4. 8.1.3 North America Blinatumomab Price by Type (2021-2032)
  5. 8.2 North America Blinatumomab Market Size by Application
  6. 8.2.1 North America Blinatumomab Revenue by Application (2021-2032)
  7. 8.2.2 North America Blinatumomab Sales by Application (2021-2032)
  8. 8.2.3 North America Blinatumomab Price by Application (2021-2032)
  9. 8.3 North America Blinatumomab Market Size by Country
  10. 8.3.1 North America Blinatumomab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Blinatumomab Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Blinatumomab Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Blinatumomab Market Size by Type
  2. 9.1.1 Europe Blinatumomab Revenue by Type (2021-2032)
  3. 9.1.2 Europe Blinatumomab Sales by Type (2021-2032)
  4. 9.1.3 Europe Blinatumomab Price by Type (2021-2032)
  5. 9.2 Europe Blinatumomab Market Size by Application
  6. 9.2.1 Europe Blinatumomab Revenue by Application (2021-2032)
  7. 9.2.2 Europe Blinatumomab Sales by Application (2021-2032)
  8. 9.2.3 Europe Blinatumomab Price by Application (2021-2032)
  9. 9.3 Europe Blinatumomab Market Size by Country
  10. 9.3.1 Europe Blinatumomab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Blinatumomab Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Blinatumomab Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Blinatumomab Market Size by Type
  2. 10.1.1 China Blinatumomab Revenue by Type (2021-2032)
  3. 10.1.2 China Blinatumomab Sales by Type (2021-2032)
  4. 10.1.3 China Blinatumomab Price by Type (2021-2032)
  5. 10.2 China Blinatumomab Market Size by Application
  6. 10.2.1 China Blinatumomab Revenue by Application (2021-2032)
  7. 10.2.2 China Blinatumomab Sales by Application (2021-2032)
  8. 10.2.3 China Blinatumomab Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Blinatumomab Market Size by Type
  2. 11.1.1 Asia Blinatumomab Revenue by Type (2021-2032)
  3. 11.1.2 Asia Blinatumomab Sales by Type (2021-2032)
  4. 11.1.3 Asia Blinatumomab Price by Type (2021-2032)
  5. 11.2 Asia Blinatumomab Market Size by Application
  6. 11.2.1 Asia Blinatumomab Revenue by Application (2021-2032)
  7. 11.2.2 Asia Blinatumomab Sales by Application (2021-2032)
  8. 11.2.3 Asia Blinatumomab Price by Application (2021-2032)
  9. 11.3 Asia Blinatumomab Market Size by Country
  10. 11.3.1 Asia Blinatumomab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Blinatumomab Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Blinatumomab Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Blinatumomab Market Size by Type
  2. 12.1.1 SAMEA Blinatumomab Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Blinatumomab Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Blinatumomab Price by Type (2021-2032)
  5. 12.2 SAMEA Blinatumomab Market Size by Application
  6. 12.2.1 SAMEA Blinatumomab Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Blinatumomab Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Blinatumomab Price by Application (2021-2032)
  9. 12.3 SAMEA Blinatumomab Market Size by Country
  10. 12.3.1 SAMEA Blinatumomab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Blinatumomab Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Blinatumomab Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Blinatumomab Value Chain Analysis
  2. 13.1.1 Blinatumomab Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Blinatumomab Production Mode & Process
  6. 13.2 Blinatumomab Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Blinatumomab Distributors
  9. 13.2.3 Blinatumomab Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst